These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [For the first time a combination of 2 protease inhibitors investigated]. Schenk M Dtsch Med Wochenschr; 1996 Aug; 121(34-35):A36. PubMed ID: 8829900 [No Abstract] [Full Text] [Related]
11. Ritonavir/saquinavir trial announced. J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):59. PubMed ID: 11363522 [TBL] [Abstract][Full Text] [Related]
12. Ritonavir: first to prolong survival. MacDougall DS J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517 [TBL] [Abstract][Full Text] [Related]
13. Matching up ritonavir with saquinavir. GMHC Treat Issues; 1996 Apr; 10(4):8. PubMed ID: 11363708 [TBL] [Abstract][Full Text] [Related]
14. Protease inhibitors: ritonavir and saquinavir combination trial recruiting--seven U.S., Canada sites incl. San Francisco. AIDS Treat News; 1996 Apr; (no 245):1-3. PubMed ID: 11363621 [TBL] [Abstract][Full Text] [Related]
15. New protease drug shows early promise. Levin J BETA; 1995 Sep; ():27, 33. PubMed ID: 11362887 [TBL] [Abstract][Full Text] [Related]
16. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration. Schouten JT STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592 [TBL] [Abstract][Full Text] [Related]
17. What's new and what's next. Fakuda D Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053 [TBL] [Abstract][Full Text] [Related]
18. AIDS drugs lurch towards market. Steele F Nat Med; 1995 Apr; 1(4):285-6. PubMed ID: 7585051 [No Abstract] [Full Text] [Related]
19. Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy. Condra JH; Petropoulos CJ; Ziermann R; Schleif WA; Shivaprakash M; Emini EA J Infect Dis; 2000 Sep; 182(3):758-65. PubMed ID: 10950769 [TBL] [Abstract][Full Text] [Related]